Though clinical data on the treatment efficiency of repolarizing agents is limited, it is clear that CD47-SIRPα, CD40/CD40L, and CSF-1/CSF-1R molecular pathways are involved in tumor survival and progression. This evidence concerns the gene CSF1R and neoplasm.